Minnesota SF3299 mandates fair pricing for community pharmacy reimbursements, prohibiting reductions below NADAC or WAC.
Minnesota SF3299 requires pharmacy benefit managers and managed care organizations to reimburse community pharmacies at or above the National Average Drug Acquisition Cost (NADAC) or Wholesale Acquisition Cost (WAC) for any prescription drug. It prohibits any direct or indirect reductions, including fees, recoupments, adjustments, or reimbursement reductions, ensuring community pharmacies receive fair compensation. The bill also mandates parity in reimbursement between community pharmacies and PBM-owned or affiliated pharmacies, prohibiting higher rates for the latter.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.